Logo

Vol. 124, No. 11

November 27, 2014
On this page
Should we use intensive hypoglycemic treatment in patients with advanced type 2 diabetes?
Spyridoula Maraka, Oscar L. Morey‑Vargas, Victor M. Montori
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 657–658; DOI: 10.20452/pamw.2544
Should we use β‑blockers for myocardial infarction?
Emmanuelle Duceppe, P.J. Devereaux
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 569–572; DOI: 10.20452/pamw.2487
Associations between the incidence of antiphosphatidylserine and antiphosphatidylethanolamine antibodies and clinical manifestations of systemic lupus erythematosus
Filip Butkiewicz, Michał Kaszuba, Michał Brzeziński, Jan Iżbicki, Marek Kubiś, Hubert Łopiński, Michał Borowiak, Michał Szelepajło, Katarzyna Fischer, Jacek Fliciński
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 573–578; DOI: 10.20452/pamw.2489
Potential pathogenic role of soluble receptor activator of nuclear factor-ĸB ligand and osteoprotegerin in patients with pulmonary arterial hypertension
Małgorzata Jasiewicz, Małgorzata Knapp, Ewa Waszkiewicz, Włodzimierz J. Musiał, Karol A. Kamiński
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 579–586; DOI: 10.20452/pamw.2491
Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1
Maciej Machaczka, Alicja Markuszewska-Kuczyńska, Sofie Regenthal, Artur Jurczyszyn, Krystyna Gałązka, Björn E. Wahlin, Monika Klimkowska
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 587–592; DOI: 10.20452/pamw.2493
Cardiovascular risk in patients undergoing maintenance hemodialysis with Helixone® membrane: a multicenter randomized study
Alicja Dębska‑Ślizień, Sylwia Małgorzewicz, Maria Dudziak, Andrzej Książek, Władysław Sułowicz, Władysław Grzeszczak, Maria Stanek‑Piotrowska, Michał Myśliwiec, Ryszard Nowaczyk, Dariusz Świetlik, Bolesław Rutkowski
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 593–598; DOI: 10.20452/pamw.2495
Reduced intake of dietary antioxidants can impair antioxidant status in type 2 diabetes patients
Małgorzata E. Zujko, Anna M. Witkowska, Maria Górska, Juliusz Wilk, Adam Krętowski
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 599–607; DOI: 10.20452/pamw.2497
Cardiovascular disease and kidney transplantation‑evaluation of potential transplant recipient
Jolanta Małyszko, Hanna Bachorzewska‑Gajewska, Anna Tomaszuk‑Kazberuk, Joanna Matuszkiewicz‑Rowińska, Magdalena Durlik, Sławomir Dobrzycki
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 608–616; DOI: 10.20452/pamw.2499
The fibrin network in diabetes: its role in thrombosis risk
Zeyad Kurdee, Rhodri King, Ramzi A. Ajjan
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 617–627; DOI: 10.20452/pamw.2501
Postcapillary pulmonary hypertension in the course of a fulminant neoplastic disease
Błażej Kusz, Marek Grabka, Krzysztof Januszewski, Wojciech Rychlik, Katarzyna Mizia‑Stec
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 637–638; DOI: 10.20452/pamw.2507
Unexpected cause of anemia: metastasis of neuroendocrine tumor to the bone marrow
Grzegorz Helbig, Anita Straczyńska‑Niemiec, Izabela Szewczyk, Elżbieta Nowicka, Grażyna Bierzyńska‑Macyszyn, Sławomira Kyrcz‑Krzemień
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 635–636; DOI: 10.20452/pamw.2505
Urgent monitoring of dabigatran plasma levels: sometimes less is more
Giuseppe Lippi, Emmanuel J. Favaloro
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 639–640; DOI: 10.20452/pamw.2509
Urgent monitoring of dabigatran plasma levels: sometimes less is more. Authors' reply
Jarosław Zalewski, Anetta Undas
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 640–641; DOI: 10.20452/pamw.2511
Our prescription drugs kill us in large numbers
Peter C. Gøtzsche
Pol Arch Intern Med. 2014, Vol. 124, No. 11: 628–634; DOI: 10.20452/pamw.2503